Patients with metabolic syndrome have prolonged corrected QT interval (QTc)

Clinical Cardiology

Volumn 32, Issue 12, 2009, Pages

  Li, Weiju ^a,d   Bai, Yongyi ^a,d   Sun, Kai ^b,c   Xue, Hao ^a,d   Wang, Yibo ^b,c   Song, Xiaodong ^b,c   Fan, Xiaohan ^a,d   Song, Huijun ^a,d   Han, Yunfeng ^a,d   Hui, Rutai ^a,b,c,d  

^a FUWAI HOSPITAL   (China)

^b Key Laboratory of Clinical Cardiovascular Genetics Ministry of Education   (China)

^c Sino German Laboratory for Molecular Medicine   (China)

^d PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

Metabolic syndrome; QTc; Risk factor

Indexed keywords

POTASSIUM;

ADULT; AGED; ARTICLE; CALCULATION; CARDIOVASCULAR RISK; CORRELATION ANALYSIS; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HEART VENTRICLE SEPTUM DEFECT; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; METABOLIC SYNDROME X; MORBIDITY; MORTALITY; PATHOPHYSIOLOGY; POTASSIUM BLOOD LEVEL; QT PROLONGATION; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; ELECTROCARDIOGRAM PATTERN; ELECTROCARDIOGRAPHY; FEMALE; HEART SEPTUM; HEART VENTRICLES; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; POTASSIUM; SEX FACTORS;

EID: 74849085560     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.20416     Document Type: Article

References (25)

1. Dekker JM, Schouten EG, Klootwijk P, Pool J, Kromhout D: Association between QT interval and coronary heart disease in middle-aged and elderly men. The Zutphen Study. Circulation. 1994;90(2):779-785.
2. Goldberg RJ, Bengtson J, Chen ZY, Anderson KM, Locati E, et al.: Duration of the QT interval and total and cardiovascularmortality in healthy persons (The Framingham Heart Study experience). Am J Cardiol. 1991;67(1):55-58.
3. Rautaharju PM,Manolio TA, Psaty BM, Borhani NO, Furberg CD: Correlates of QT prolongation in older adults (the Cardiovascular Health Study). Cardiovascular Health Study Collaborative Research Group. Am J Cardiol. 1994;73(13):999-1002.
4. Nakanishi S, Yamada M, Hattori N, Suzuki G: Relation between QT duration and mortality in an elderly Japanese population. Am J Cardiol. 2004;93(9):1182-1185.
5. Wong KY, McSwiggan S, Kennedy NS, Wong SY, Gavin A, et al.: Spectrum of cardiac abnormalities associated with long QT in stroke survivors. Heart. 2005;91(10):1306-1310.
6. Rana BS, Lim PO, Naas AA, Ogston SA, Newton RW, et al.: QT interval abnormalities are often present at diagnosis in diabetes and are better predictors of cardiac death than ankle brachial pressure index and autonomic function tests. Heart. 2005;91(1):44-50.
7. SoRelle R: QTc interval and B-type natriuretic peptide levels predict death in patients with advanced heart failure. Circulation. 2003;107(13):e9024-e9032.
8. Arildsen H, May O, Christiansen EH, Damsgaard EM: Increased QT dispersion in patients with insulin-dependent diabetes mellitus. Int J Cardiol. 1999;71(3):235-242.
9. Soydinc S, Davutoglu V, Akcay M: Uncomplicated metabolic syndrome is associated with prolonged electrocardiographic QTc interval and QTc dispersion. Ann Noninvasive Electrocardiol. 2006;11(4):313-317.
10. Pietrobelli A, Rothacker D, Gallagher D, Heymsfield SB: Electrocardiographic QTC interval: Short-term weight loss effects. Int J Obes Relat Metab Disord. 1997;21(2):110-114.
11. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, et al.: Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112(17): 2735-2752.
12. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, et al.: Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42(6):1206-1252.
13. Rautaharju PM, Wolf HK, Eifler WJ, Blackburn H: A simple procedure for positioning precordial ECG and VCG electrodes using an electrode locator. J Electrocardiol. 1976;9(1):35-40.
14. Cowan JC, Yusoff K, Moore M, Amos PA, Gold AE, et al.: Importance of lead selection in QT interval measurement. Am J Cardiol. 1988;61(1):83-87.
15. Toivonen L: More light on QT interval measurement. Heart. 2002;87(3):193-194.
16. Harris RI, Steare SE: A meta-analysis of ECG data from healthy male volunteers: Diurnal and intra-subject variability, and implications for planning ECG assessments and statistical analysis in clinical pharmacology studies. Eur J Clin Pharmacol. 2006;62(11):893-903.
17. Banker J, Dizon J, Reiffel J: Effects of the ventricular activation sequence on the JT interval. Am J Cardiol. 1997;79(6):816-819.
18. The assessment of the potential for QT interval prolongation by non-cardiovascular medicinal products. London: Committee for Proprietary Medicinal Products 1997.
19. Prineas RJ CR, Blackburn H.: The Minnesota Code Manual of Electrocardiographic Findings. Boston, MA: John Wright; 1982; : 223-229.
20. Tajik AJ, Seward JB, Hagler DJ, Mair DD, Lie JT: Twodimensional real-time ultrasonic imaging of the heart and great vessels. Technique, image orientation, structure identification, and validation. Mayo Clin Proc. 1978;53(5):271-303.
21. Dekker JM, Feskens EJ, Schouten EG, Klootwijk P, Pool J, et al.: QTc duration is associated with levels of insulin and glucose intolerance. The Zutphen Elderly Study. Diabetes. 1996;45(3): 376-380.
22. Ferrannini E, Galvan AQ, Gastaldelli A, Camastra S, Sironi AM, et al.: Insulin: New roles for an ancient hormone. Eur J Clin Invest. 1999;29(10):842-852.
23. Buja G,Miorelli M, Turrini P, Melacini P, Nava A: Comparison of QT dispersion in hypertrophic cardiomyopathy between patients with and without ventricular arrhythmias and sudden death. Am J Cardiol. 1993;72(12):973-976.
24. Grandinetti A, Seifried S, Mor J, Chang HK, Theriault AG: Prevalence and risk factors for prolonged QTc in a multiethnic cohort in rural Hawaii. Clin Biochem. 2005;38(2): 116-122.
25. Montague CT, O'Rahilly S: The perils of portliness: causes and consequences of visceral adiposity. Diabetes. 2000;49(6): 883-888.